HiFiBiO

About:

HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.

Website: http://www.hifibio.com

Twitter/X: hifibio

Top Investors: B Capital, HongShan, Kite Pharma, Hong Kong Science and Technology Parks Corporation, Delian Capital

Description:

HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.